(Q34244286)

31 July 2017

1 reference

title

Low-molecular-weight heparin during pregnancy (English)

1 reference

31 July 2017

1 reference

Bazzan M

1

1 reference

31 July 2017

Donvito V

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

101

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

V175-86

1 reference

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Low molecular weight heparin use during pregnancy: issues of safety and practicality

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Venous thrombotic complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Thrombosis in pregnancy: maternal and fetal issues

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

High levels of coagulation factor XI as a risk factor for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Heritable coagulopathies in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

The role of inherited thrombophilia in venous thromboembolism associated with pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Maternal and fetal sequelae of anticoagulation during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Chondrodysplasis punctata: is maternal warfarin therapy a factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

May mothers given warfarin breast-feed their infants?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Is warfarin sodium contraindicated in the lactating mother?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Use of antithrombotic agents during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Outcome of pregnancy in women with valve prostheses

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Prevention of pre-eclampsia by early antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Thrombophilias and adverse outcomes of pregnancy--what should a clinician do?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900403-5

7 January 2021

10.1016/S0049-3848(00)00403-5

Identifiers

DOI

1 reference

31 July 2017

1 reference